Press Releases
-
Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service
Nov 21, 2022
-
Dolomite Bio launches RNAdia 2.0 Reagent Kit – Fast, Easy, Robust
Dolomite Bio has announced the launch of the RNAdia 2.0 reagent kit for single cell research. At a significantly lower cost compared to competitor reagents the new and improved RNAdia 2.0 kit alleviates that stress, allowing researchers to focus on what is important, doing more and discovering more.
Nov 29, 2022
-
UK Supplier expands to provide Chemically Defined & Serum-Free Cell Media Solutions for the Cell and Gene Therapy Industry
BioPharma Dynamics has announced the expansion of its extensive portfolio to offer a range of chemically defined T-Cell Media, DMSO-Free Cryopreservation Solutions, and Recombinant Growth Factors, for the Cell & Gene Therapy market.
Nov 29, 2022
-
Biopharma PEG Develops PEG Products For Click Chemistry
Nov 29, 2022
-
Huateng Pharma Supplies Semaglutide Intermediates Against Type 2 Diabetes
Nov 28, 2022
-
Genezen appoints Chief Commercial Officer to Executive Leadership Team
Genezen appoints Jeff Whitmore as CCO
Nov 28, 2022
-
Andelyn Biosciences to Manufacture First Gene Therapy for Infantile Neuroaxonal Dystrophy in the US
Nov 28, 2022
-
Creative Enzymes Expands Its Service Offering with the Launch of Custom Enzyme Blends
Nov 28, 2022
-
Creative Enzymes Provides DNA Molecular Weight Markers and Ladders
Nov 14, 2022
-
CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing
Nov 18, 2022
-
MicrobioSeq Boosts Scientific Research with Gene Expression Analysis
Nov 14, 2022
-
Micro-Sphere Launches New Research & Development Services at Swiss Site
Global contract development and manufacturing organisation (CDMO) Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.
Nov 27, 2022
-
Zebrafish Disease Model: Developed by Creative Biogene to Support Multiple Therapeutic Areas
Nov 27, 2022
-
IntegrateRNA Develops Premade Circular RNA Products to Satisfy Various Downstream Applications
Nov 27, 2022
-
Microbiosci Develops Data-independent Acquisition Proteomics to Support Molecular Diagnostics
Nov 27, 2022
-
Creative Bioarray Develops More Than 1000 Cell Types Together with Selective Cell Culture Media
Nov 27, 2022
-
Creative Bioarray Releases GMP Grade Cytokines to Support Cell Manufacturing and Cell-based Therapies
Nov 27, 2022
-
Acroscell Develops CiPA in Silico Modeling to Identify and Optimize Drug Candidates
Nov 27, 2022
-
Chantal van Gils joins NDA Advisory Board as Director of Epidemiology and Real-World Evidence
NDA Group has announced that Chantal van Gils NDA, MD, Ph.D., specialist in epidemiological analyses and outcome research, joins the NDA Advisory Board as Director of Epidemiology and Real-World Evidence.
Nov 23, 2022
-
uMotif Announces First New Validated Innovation in eCOA/ePRO Since Paper Instruments Were Deployed on Smartphones
uMotif's patent-protected Motif data capture interface is proven as an equivalent method to capture Patient Reported Outcome and eDiary data, eliminating reliance on text-based instruments, in a study with 55 participants in 2 randomized groups conducted by SAFIRA Clinical Research at Dublin City University
Nov 17, 2022






